CS Diagnostics Corp. is a medical distribution company that provides the advancing patient care through innovative solutions. The company is headquartered in Neuss, Nordrhein-Westfalen. The company went IPO on 2005-02-23. The firm is engaged in designing, manufacturing, and selling wellness and medical products. The company focuses on improving therapy outcomes and reducing side effects. The company is revolutionizing patient care on a global scale. One of these products is the CS Protect Hydrogel. The company serves a varied international market and specializes in traversing complicated regulatory landscapes to gain product approval and distribution.
